The following statement can be attributed to Brian Peters, CEO of the Michigan Health & Hospital Association.
The approval of an emergency use authorization for the Johnson & Johnson COVID-19 vaccine is another significant step toward ending the pandemic. The availability of a safe and effective single-dose vaccine will help Michigan vaccinate our population, especially those vulnerable and harder to reach residents, more quickly. The Johnson & Johnson vaccine demonstrated complete protection against COVID-19-related hospitalization and death 28 days post-vaccination in its clinical trials. The addition of a third approved vaccine will also help alleviate existing vaccine supply constraints and quicken the pace of administering vaccines.
Hospitals will continue to assist with vaccination efforts as more details are released by federal and state entities about how this new vaccine should be put to use.
The following statement on the Food and Drug Administration (FDA) approval of the Pfizer COVID-19 vaccine can be attributed to Brian Peters, CEO of the Michigan Health & Hospital Association.
Last night’s action by the FDA to issue emergency use authorization for the Pfizer COVID-19 vaccine is a crucial first step toward the path of ending the pandemic. The data available show that this vaccine is safe and effective. Shortly, hospitals across Michigan will begin vaccinating healthcare workers who have been serving at the front lines of the pandemic for the past nine months. An approved COVID-19 vaccine is the biggest step toward protecting front-line caregivers since the pandemic began.
We still have a long road ahead toward vaccinating all Michiganders that will require the commitment of the public to continue COVID-19 prevention efforts including mask wearing, avoiding social gatherings, getting flu shots and practicing proper hand hygiene.